StockData
iSpecimen Inc. logo

iSpecimen Inc. (ISPC) stock

ISPCNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 17, 2026Score 7/3045% below fair value
$0.53−0.06 (-10.57%)

Close on Nov 18, 2026Market cap $1.34MP/E –Yield –

iSpecimen free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

iSpecimen's free cash flow for the twelve months ending Dec 31, 2025 was -$4.24M. For fiscal 2025 it was -$4.24M. The highest annual figure on record is -$288.81K in fiscal 2020.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$4.24M–
FY2024Dec 31, 2024-$8.30M–
FY2023Dec 31, 2023-$5.83M–
FY2022Dec 31, 2022-$6.03M–
FY2021Dec 31, 2021-$10.67M–
FY2020Dec 31, 2020-$288.81K–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2025Dec 31, 2025-$916.92K–
Q3 FY2025Sep 30, 2025-$2.04M–
Q4 FY2024Dec 31, 2024-$3.58M-1137.4%
Q3 FY2024Sep 30, 2024-$1.09M–
Q2 FY2024Jun 30, 2024-$1.54M–
Q1 FY2024Mar 31, 2024-$2.08M–
Q4 FY2023Dec 31, 2023$345.14K–
Q3 FY2023Sep 30, 2023-$1.64M–
Q2 FY2023Jun 30, 2023-$1.70M–
Q1 FY2023Mar 31, 2023-$2.83M–
Q4 FY2021Dec 31, 2021-$1.32M–
Q3 FY2021Sep 30, 2021-$6.08M–
Q4 FY2020Dec 31, 2020-$24.07K–
Q3 FY2020Sep 30, 2020-$319.41K–

More iSpecimen figures

See a number that looks wrong?